Long-term ribavirin therapy for recurrent hepatitis C after liver transplantation

Transplantation Proceedings

Volumn 29, Issue 1-2, 1997, Pages 514-

  Aljumah, A A ^a   Cattral, M S ^a   Greig, P D ^a   Wanless, I R ^a   Krajden, M ^a   Hemming, A W ^a   Lilly, L B ^a   Levy, G A ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

RIBAVIRIN;

CHRONIC DISEASE; CLINICAL ARTICLE; CONFERENCE PAPER; ENZYME ACTIVITY; FOLLOW UP; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER TRANSPLANTATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; RELAPSE; SURVIVAL RATE;

ANTIVIRAL AGENTS; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RIBAVIRIN; RNA, VIRAL; TIME FACTORS;

EID: 0030895959     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(96)00244-8     Document Type: Conference Paper

References (3)

1. Gane EJ, Portmann BC, Naoumov NV, et al: N Engl J Med 334:815, 1996
2. Cattral MS, Krajden M, Wanless IR, et al: Transplantation 61:1483, 1996
3. Knodell RG, Ishak KG, Black WC, et al: Hepatology 1:431, 1991